Yes, but if one compares to Sirtex, Sirtex sold 67,000 doses by 2016 in over 40 countries. And the Sirtex device was also used in combination with chemo.
So, again there is no real intrinsic reason why Oncosil could not be as successful.
Oncosil is already getting close to 40 country adoptions.
EU member states: 27
UK: 1
Singapore: 1
Malaysia: 1
Switzerland: 1
NZ: 1
Adoptions Pending:
Aus: 1
Hong Kong: 1
US: Bile Duct
To sum up: 32 countries already approved. And another 3 to go.
Thumbs up if you like the analysis.
Ann: OncoSil receives Swiss regulatory approval, page-49
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
0.002(15.4%) |
Mkt cap ! $56.76M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.5¢ | 1.3¢ | $76.04K | 5.442M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 450000 | 1.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 9713598 | 7 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| OSL (ASX) Chart |